Identifying therapeutic biomarkers of zoledronic acid by metabolomics

• मुख्य लेखकों: Xiang Li (लेखक), Zi-Yuan Wang (लेखक), Na Ren (लेखक), Zhan-Ying Wei (लेखक), Wei-Wei Hu (लेखक), Jie-Mei Gu (लेखक), Zhen-Lin Zhang (लेखक), Xiang-Tian Yu (लेखक), Chun Wang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Zoledronic acid (ZOL) is a potent antiresorptive agent that increases bone mineral density (BMD) and reduces fracture risk in postmenopausal osteoporosis (PMOP). The anti-osteoporotic effect of ZOL is determined by annual BMD measurement. In most cases, bone turnover markers function as early indica...